{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:41Z","timestamp":1793170061482,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20233167"],"award-info":[{"award-number":["GZC20233167"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88657-2","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T15:12:36Z","timestamp":1738768356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Ying","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"1","key":"88657_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12957-020-01948-y","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang, W., Yang, Z. & Ouyang, Q. A nomogram to predict skip metastasis in papillary thyroid cancer. World J. Surg. Oncol. 18 (1), 167 (2020).","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"88657_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jncc.2020.12.001","volume":"1","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Cancer incidence and mortality in China, 2015. J. Natl. Cancer Cent. 1 (1), 2\u201311 (2021).","journal-title":"J. Natl. Cancer Cent."},{"key":"88657_CR3","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.2147\/CMAR.S218179","volume":"11","author":"W Wang","year":"2019","unstructured":"Wang, W., Meng, C., Ouyang, Q., Xie, J. & Li, X. Magnesemia: an independent risk factor of hypocalcemia after thyroidectomy. Cancer Manag. Res. 11, 8135\u20138144 (2019).","journal-title":"Cancer Manag Res."},{"issue":"13","key":"88657_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.21037\/atm-21-383","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Identification and validation of potential novel biomarkers to predict distant metastasis in differentiated thyroid cancer. Annals Transl.  Med. 9 (13), 1053\u20131053 (2021).","journal-title":"Annals Translational Med."},{"key":"88657_CR5","doi-asserted-by":"crossref","unstructured":"Ding, Y. & Zhou, R. Distant lymph node metastasis in differentiated thyroid cancer: a population-based cohort study. Surgeon (2024).","DOI":"10.1016\/j.surge.2024.07.004"},{"issue":"1","key":"88657_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","volume":"20","author":"P Nombela","year":"2021","unstructured":"Nombela, P., Miguel-Lopez, B. & Blanco, S. The role of m(6)A, m(5)C and psi RNA modifications in cancer: novel therapeutic opportunities. Mol. Cancer  20 (1), 18 (2021).","journal-title":"Mol. Cancer"},{"issue":"6","key":"88657_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/cr.2017.73","volume":"27","author":"D Dominissini","year":"2017","unstructured":"Dominissini, D. & Rechavi, G. 5-methylcytosine mediates nuclear export of mRNA. Cell. Res. 27 (6), 717\u2013719 (2017).","journal-title":"Cell. Res."},{"issue":"1","key":"88657_CR8","doi-asserted-by":"publisher","first-page":"e1510","DOI":"10.1002\/wrna.1510","volume":"10","author":"L Trixl","year":"2019","unstructured":"Trixl, L. & Lusser, A. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip. Rev. RNA  10 (1), e1510 (2019).","journal-title":"Wiley Interdiscip Rev. RNA"},{"key":"88657_CR9","doi-asserted-by":"publisher","first-page":"657466","DOI":"10.3389\/fonc.2021.657466","volume":"11","author":"J Pan","year":"2021","unstructured":"Pan, J., Huang, Z. & Xu, Y. m5C RNA methylation regulators predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Front. Oncol. 11, 657466 (2021).","journal-title":"Front. Oncol."},{"issue":"5","key":"88657_CR10","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.21037\/tlcr-21-351","volume":"10","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. M(5)C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in lung adenocarcinoma. Transl. Lung Cancer Res. 10 (5), 2172\u20132192 (2021).","journal-title":"Transl Lung Cancer Res."},{"issue":"9","key":"88657_CR11","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/jcb.25957","volume":"118","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. NSUN2-mediated m5C methylation and METTL3\/METTL14-mediated m6A methylation cooperatively enhance p21 translation. J. Cell. Biochem. 118 (9), 2587\u20132598 (2017).","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"88657_CR12","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1038\/s41467-020-16722-7","volume":"11","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. M(5)C modification of mRNA serves a DNA damage code to promote homologous recombination. Nat. Commun. 11 (1), 2834 (2020).","journal-title":"Nat. Commun."},{"issue":"8","key":"88657_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat. Cell. Biol. 21 (8), 978\u2013990 (2019).","journal-title":"Nat. Cell. Biol."},{"key":"88657_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2018.05.013","volume":"430","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma. Cancer Lett. 430, 57\u201366 (2018).","journal-title":"Cancer Lett."},{"issue":"2","key":"88657_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ijc.32520","volume":"146","author":"A Carella","year":"2020","unstructured":"Carella, A. et al. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis. Int. J. Cancer 146 (2), 373\u2013387 (2020).","journal-title":"Int. J. Cancer"},{"key":"88657_CR16","doi-asserted-by":"crossref","unstructured":"Ferrari, S. M. et al. Immune and inflammatory cells in thyroid cancer microenvironment. Int. J. Mol. Sci. 20 (18). (2019).","DOI":"10.3390\/ijms20184413"},{"issue":"4","key":"88657_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1089\/thy.2018.0687","volume":"29","author":"Z Hurst","year":"2019","unstructured":"Hurst, Z. et al. Risk haplotypes uniquely associated with radioiodine-refractory thyroid cancer patients of high African ancestry. Thyroid 29 (4), 530\u2013539 (2019).","journal-title":"Thyroid"},{"issue":"6","key":"88657_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","volume":"38","author":"RJ Motzer","year":"2020","unstructured":"Motzer, R. J. et al. Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade. Cancer Cell. 38 (6), 803\u2013817e804 (2020).","journal-title":"Cancer Cell."},{"issue":"13","key":"88657_CR19","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-16-3556","volume":"77","author":"A Prat","year":"2017","unstructured":"Prat, A. et al. Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma. Cancer Res. 77 (13), 3540\u20133550 (2017).","journal-title":"Cancer Res."},{"issue":"7","key":"88657_CR20","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao, Y. R. et al. ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Adv. Sci. 7 (7), 1902880 (2020).","journal-title":"Adv. Sci."},{"issue":"D1","key":"88657_CR21","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"88657_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"88657_CR23","doi-asserted-by":"crossref","unstructured":"Wang, W., Bai, N. & Li, X. Comprehensive analysis of the prognosis and drug sensitivity of differentiation-related lncRNAs in papillary thyroid cancer. Cancers (Basel) 14 (5). (2022).","DOI":"10.3390\/cancers14051353"},{"key":"88657_CR24","doi-asserted-by":"publisher","first-page":"139150","DOI":"10.1016\/j.ijbiomac.2024.139150","volume":"291","author":"Y Ding","year":"2024","unstructured":"Ding, Y., Liu, M., Wang, W. & Li, X. YTHDF3-induced degradation of P4HA2 mRNA inhibits glycolysis in papillary thyroid cancer through hippo signaling pathway. Int. J. Biol. Macromol. 291, 139150 (2024).","journal-title":"Int. J. Biol. Macromol."},{"issue":"15","key":"88657_CR25","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.7150\/thno.35219","volume":"9","author":"X Su","year":"2019","unstructured":"Su, X. et al. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK\/ERK and PI3K\/AKT pathways via distinct mechanisms. Theranostics 9 (15), 4461\u20134473 (2019).","journal-title":"Theranostics"},{"issue":"10","key":"88657_CR26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1089\/thy.2018.0186","volume":"28","author":"SA Ghaznavi","year":"2018","unstructured":"Ghaznavi, S. A. et al. Using the American thyroid association risk-stratification system to refine and individualize the American joint committee on cancer eighth edition disease-specific survival estimates in differentiated thyroid cancer. Thyroid 28 (10), 1293\u20131300 (2018).","journal-title":"Thyroid"},{"key":"88657_CR27","doi-asserted-by":"publisher","first-page":"719820","DOI":"10.3389\/fcell.2021.719820","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. The role of m6A RNA methylation-related lncRNAs in the prognosis and tumor immune microenvironment of papillary thyroid carcinoma. Front. Cell. Dev. Biol. 9, 719820 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"45","key":"88657_CR28","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun, Z. et al. Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene 39 (45), 6906\u20136919 (2020).","journal-title":"Oncogene"},{"key":"88657_CR29","doi-asserted-by":"publisher","first-page":"633415","DOI":"10.3389\/fonc.2021.633415","volume":"11","author":"C Xue","year":"2021","unstructured":"Xue, C., Zhao, Y., Li, G. & Li, L. Multi-omic analyses of the m(5)C Regulator ALYREF reveal its essential roles in hepatocellular carcinoma. Front. Oncol. 11, 633415 (2021).","journal-title":"Front. Oncol."},{"key":"88657_CR30","doi-asserted-by":"publisher","first-page":"599340","DOI":"10.3389\/fmolb.2020.599340","volume":"7","author":"S Xiang","year":"2020","unstructured":"Xiang, S. et al. M(5)C RNA methylation primarily affects the ErbB and PI3K-Akt signaling pathways in gastrointestinal cancer. Front. Mol. Biosci. 7, 599340 (2020).","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"88657_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.21037\/atm-20-3744","volume":"8","author":"L Sun","year":"2020","unstructured":"Sun, L. et al. Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma. Ann. Transl Med. 8 (12), 751 (2020).","journal-title":"Ann. Transl Med."},{"issue":"1","key":"88657_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","volume":"68","author":"J Wang","year":"2020","unstructured":"Wang, J., Yu, F., Shang, Y., Ping, Z. & Liu, L. Thyroid cancer: incidence and mortality trends in China, 2005\u20132015. Endocrine 68 (1), 163\u2013173 (2020).","journal-title":"Endocrine"},{"issue":"6","key":"88657_CR33","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4161\/rna.24454","volume":"10","author":"T Amort","year":"2014","unstructured":"Amort, T. et al. Long non-coding RNAs as targets for cytosine methylation. RNA Biol. 10 (6), 1002\u20131008 (2014).","journal-title":"RNA Biol."},{"issue":"2","key":"88657_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.celrep.2013.06.029","volume":"4","author":"S Hussain","year":"2013","unstructured":"Hussain, S. et al. NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs. Cell. Rep. 4 (2), 255\u2013261 (2013).","journal-title":"Cell. Rep."},{"issue":"1","key":"88657_CR35","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-019-10020-7","volume":"10","author":"AA Sajini","year":"2019","unstructured":"Sajini, A. A. et al. Loss of 5-methylcytosine alters the biogenesis of vault-derived small RNAs to coordinate epidermal differentiation. Nat. Commun. 10 (1), 2550 (2019).","journal-title":"Nat. Commun."},{"issue":"11","key":"88657_CR36","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1093\/nar\/gks144","volume":"40","author":"JE Squires","year":"2012","unstructured":"Squires, J. E. et al. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 40 (11), 5023\u20135033 (2012).","journal-title":"Nucleic Acids Res."},{"key":"88657_CR37","doi-asserted-by":"publisher","first-page":"671821","DOI":"10.3389\/fcell.2021.671821","volume":"9","author":"J Pan","year":"2021","unstructured":"Pan, J., Huang, Z. & Xu, Y. m5C-related lncRNAs predict overall survival of patients and regulate the tumor immune microenvironment in lung adenocarcinoma. Front. Cell. Dev. Biol. 9, 671821 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"88657_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24 (5), 541\u2013550 (2018).","journal-title":"Nat. Med."},{"issue":"9","key":"88657_CR39","doi-asserted-by":"publisher","first-page":"e199292","DOI":"10.1001\/jamanetworkopen.2019.9292","volume":"2","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Association of germline variants in natural killer cells with tumor immune microenvironment subtypes, tumor-infiltrating lymphocytes, immunotherapy response, clinical outcomes, and cancer risk. JAMA Netw. Open 2 (9), e199292 (2019).","journal-title":"JAMA Netw. Open."},{"issue":"18","key":"88657_CR40","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1111\/febs.14934","volume":"286","author":"K Schoeler","year":"2019","unstructured":"Schoeler, K. et al. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells. FEBS J. 286 (18), 3566\u20133581 (2019).","journal-title":"FEBS J."},{"issue":"2","key":"88657_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2014.11.004","volume":"358","author":"W Mou","year":"2015","unstructured":"Mou, W. et al. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment. Cancer Lett. 358 (2), 115\u2013123 (2015).","journal-title":"Cancer Lett."},{"key":"88657_CR42","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fcell.2020.00672","volume":"8","author":"Q Lei","year":"2020","unstructured":"Lei, Q., Wang, D., Sun, K., Wang, L. & Zhang, Y. Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors. Front. Cell. Dev. Biol. 8, 672 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"11","key":"88657_CR43","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","volume":"21","author":"S Kumagai","year":"2020","unstructured":"Kumagai, S. et al. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nat. Immunol. 21 (11), 1346\u20131358 (2020).","journal-title":"Nat. Immunol."},{"key":"88657_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2019.10.036","volume":"469","author":"T Akin Telli","year":"2020","unstructured":"Akin Telli, T. et al. PD-1 and PD-L1 inhibitors in oesophago-gastric cancers. Cancer Lett. 469, 142\u2013150 (2020).","journal-title":"Cancer Lett."},{"key":"88657_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.oraloncology.2018.11.003","volume":"87","author":"SH Nam","year":"2018","unstructured":"Nam, S. H. et al. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma. Oral Oncol. 87, 158\u2013164 (2018).","journal-title":"Oral Oncol."},{"issue":"2","key":"88657_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/thy.2017.0265","volume":"28","author":"M Shteinshnaider","year":"2018","unstructured":"Shteinshnaider, M. et al. Reassessment of differentiated thyroid cancer patients using the eighth TNM\/AJCC classification system: a comparative study. Thyroid 28 (2), 201\u2013209 (2018).","journal-title":"Thyroid"},{"key":"88657_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.oraloncology.2017.06.004","volume":"71","author":"TH Kim","year":"2017","unstructured":"Kim, T. H. et al. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma. Oral Oncol. 71, 81\u201386 (2017).","journal-title":"Oral Oncol."},{"issue":"12","key":"88657_CR48","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1593\/neo.111060","volume":"13","author":"L Zhou","year":"2011","unstructured":"Zhou, L. et al. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt\/beta-catenin signaling linked to the PDGFR\/Src and Rac\/PAK pathways. Neoplasia 13 (12), 1101\u20131112 (2011).","journal-title":"Neoplasia"},{"issue":"2","key":"88657_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ijc.32935","volume":"147","author":"G Benvenuto","year":"2020","unstructured":"Benvenuto, G. et al. Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer. Int. J. Cancer  147 (2), 565\u2013574 (2020).","journal-title":"Int. J. Cancer"},{"key":"88657_CR50","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1038\/ncomms3976","volume":"4","author":"I Serrano","year":"2013","unstructured":"Serrano, I., McDonald, P. C., Lock, F., Muller, W. J. & Dedhar, S. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. Nat. Commun. 4, 2976 (2013).","journal-title":"Nat. Commun."},{"issue":"10","key":"88657_CR51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov, Y. E. & Nikiforova, M. N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 7 (10), 569\u2013580 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"12","key":"88657_CR52","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1172\/JCI46382","volume":"121","author":"D Chakravarty","year":"2011","unstructured":"Chakravarty, D. et al. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J. Clin. Investig. 121 (12), 4700\u20134711 (2011).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88657-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88657-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88657-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T22:38:34Z","timestamp":1738795114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88657-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88657"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88657-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all the participants and approved by the Ethics Committee of Xiangya Hospital of Central South University (No. 202004192).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"4405"}}